Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes and atherosclerosis: is there a role for hyperglycemia?

Literature DB >> 19029122

Diabetes and atherosclerosis: is there a role for hyperglycemia?

Abstract

Atherosclerosis is accelerated in both type 1 and type 2 diabetes. The hallmark of diabetes is the presence of hyperglycemia. In this article, we review the role of glucose in the pathogenesis of atherosclerosis. Evidence obtained from epidemiological, in vitro, and animal studies will be reviewed in an attempt to understand the complex relationship between hyperglycemia and cardiovascular risk that is emerging from clinical trials.

Entities: Chemical Disease

Mesh：

Substances：
Glucose

Year: 2008 PMID： 19029122 PMCID： PMC2674740 DOI： 10.1194/jlr.R800059-JLR200

Source DB: PubMed Journal: J Lipid Res ISSN： 0022-2275 Impact factor: 5.922

36 in total

1. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245

2. Diabetes-induced accelerated atherosclerosis in swine.

Authors: R G Gerrity; R Natarajan; J L Nadler; T Kimsey
Journal: Diabetes Date: 2001-07 Impact factor: 9.461

3. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice.

Authors: Reeba K Vikramadithyan; Yunying Hu; Hye-Lim Noh; Chien-Ping Liang; Kellie Hallam; Alan R Tall; Ravichandran Ramasamy; Ira J Goldberg
Journal: J Clin Invest Date: 2005-08-25 Impact factor: 14.808

4. Upregulation of glucose metabolism during intimal lesion formation is coupled to the inhibition of vascular smooth muscle cell apoptosis. Role of GSK3beta.

Authors: J L Hall; J C Chatham; H Eldar-Finkelman; G H Gibbons
Journal: Diabetes Date: 2001-05 Impact factor: 9.461

5. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells.

Authors: Rosaria Piga; Yuji Naito; Satoshi Kokura; Osamu Handa; Toshikazu Yoshikawa
Journal: Atherosclerosis Date: 2006-11-13 Impact factor: 5.162

Review 6. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

Authors: João Costa; Margarida Borges; Cláudio David; António Vaz Carneiro
Journal: BMJ Date: 2006-04-03

Review 7. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?

Authors: Jenny E Kanter; Fredrik Johansson; Renee C LeBoeuf; Karin E Bornfeldt
Journal: Circ Res Date: 2007-03-30 Impact factor: 17.367

8. High glucose induces IL-1beta expression in human monocytes: mechanistic insights.

Authors: Mohan R Dasu; Sridevi Devaraj; Ishwarlal Jialal
Journal: Am J Physiol Endocrinol Metab Date: 2007-04-10 Impact factor: 4.310

9. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.

Authors: Fredrik Johansson; Farah Kramer; Shelley Barnhart; Jenny E Kanter; Tomas Vaisar; Rachel D Merrill; Linda Geng; Kazuhiro Oka; Lawrence Chan; Alan Chait; Jay W Heinecke; Karin E Bornfeldt
Journal: Proc Natl Acad Sci U S A Date: 2008-02-05 Impact factor: 11.205

10. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

Authors: C T Prince; D J Becker; T Costacou; R G Miller; T J Orchard
Journal: Diabetologia Date: 2007-09-02 Impact factor: 10.122

60 in total

Review 1. Cardiovascular disease risk in young people with type 1 diabetes.

Authors: Janet K Snell-Bergeon; Kristen Nadeau
Journal: J Cardiovasc Transl Res Date: 2012-04-12 Impact factor: 4.132

Review 2. LXRα Phosphorylation in Cardiometabolic Disease: Insight From Mouse Models.

Authors: Maud Voisin; Matthew C Gage; Natalia Becares; Elina Shrestha; Edward A Fisher; Ines Pineda-Torra; Michael J Garabedian
Journal: Endocrinology Date: 2020-07-01 Impact factor: 4.736

3. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors: Yunes Panahi; Nahid Khalili; Ebrahim Sahebi; Soha Namazi; Maryam Saberi Karimian; Muhammed Majeed; Amirhossein Sahebkar
Journal: Inflammopharmacology Date: 2016-12-07 Impact factor: 4.473

Review 4. Animal models of atherosclerosis.

Authors: Godfrey S Getz; Catherine A Reardon
Journal: Arterioscler Thromb Vasc Biol Date: 2012-03-01 Impact factor: 8.311

5. Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.

Authors: Jenny E Kanter; Baohai Shao; Farah Kramer; Shelley Barnhart; Masami Shimizu-Albergine; Tomas Vaisar; Mark J Graham; Rosanne M Crooke; Clarence R Manuel; Rebecca A Haeusler; Daniel Mar; Karol Bomsztyk; John E Hokanson; Gregory L Kinney; Janet K Snell-Bergeon; Jay W Heinecke; Karin E Bornfeldt
Journal: J Clin Invest Date: 2019-07-11 Impact factor: 14.808

6. Relation between anti-atherosclerotic effects of IRAK4 and modulation of vascular smooth muscle cell phenotype in diabetic rats.

Authors: Lijuan Cao; Defeng Pan; Dongye Li; Yanbin Zhang; Qiuping Chen; Tongda Xu; Wenhua Li; Wanling Wu
Journal: Am J Transl Res Date: 2016-02-15 Impact factor: 4.060